Pituitary enlargement in patients with PROP1 gene inactivating mutation represents cystic hyperplasia of the intermediate pituitary lobe. Histopathology and over 10 years follow-up of two patients

Journal of Pediatric Endocrinology and Metabolism

Volumn 22, Issue 7, 2009, Pages 653-660

  Zygmunt Goørska, Agata ^a   Starzyk, Jerzy ^a   Adamek, Dariusz ^a   Radwańska, Edyta ^a   Sucharski, Piotr ^a   Herman Sucharska, Izabela ^a   Pietrzyk, Jacek J ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

Cystic hyperplasia of intermediate pituitary lobe; Immunohistochemistry; Pituitary enlargement; PROP1 gene mutation

Indexed keywords

HOMEOBOX PROTEIN PROP1; HOMEODOMAIN PROTEIN; HUMAN GROWTH HORMONE; HYDROCORTISONE; INSULIN; KI 67 ANTIGEN; LEVODOPA; LEVOTHYROXINE; PROPRANOLOL; UNCLASSIFIED DRUG;

ADRENAL INSUFFICIENCY; ADULT; ARTICLE; CANCER SURGERY; CASE REPORT; CELL PROLIFERATION; CHILD; CLINICAL ASSESSMENT; CLINICAL FEATURE; COMBINED PITUITARY HORMONE DEFICIENCY; CRANIOPHARYNGIOMA; DISEASE DURATION; EOSINOPHIL; EPITHELIUM CELL; FEMALE; FOLLOW UP; GENE INACTIVATION; GENE MUTATION; GROWTH HORMONE DEFICIENCY; HISTOLOGY; HISTOPATHOLOGY; HUMAN; HYPERPLASIA; HYPOPHYSIS; HYPOPHYSIS DISEASE; HYPOPHYSIS INTERMEDIATE LOBE HYPERPLASIA; HYPOPHYSIS TUMOR; HYPOTHALAMUS HYPOPHYSIS SYSTEM; HYPOTHYROIDISM; IMMUNOHISTOCHEMISTRY; INTELLIGENCE QUOTIENT; LABORATORY TEST; MALE; NEUROHYPOPHYSIS; NEUROIMAGING; NEUROSURGERY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PHENOTYPE; PITUITARY GLAND ENLARGEMENT; PRESCHOOL CHILD; PSYCHOMOTOR DISORDER; PUBERTY; RETROSPECTIVE STUDY; SECONDARY HYPOTHYROIDISM; SHORT STATURE; THYROID PARAFOLLICULAR CELL; TREATMENT DURATION; TUMOR VOLUME;

ADOLESCENT; ADULT; CYSTS; FEMALE; HOMEODOMAIN PROTEINS; HUMANS; HYPERPLASIA; HYPOPITUITARISM; MAGNETIC RESONANCE IMAGING; MALE; PITUITARY GLAND, INTERMEDIATE; PITUITARY HORMONES; RETROSPECTIVE STUDIES;

EID: 69949156456     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Gage PJ, Brinkmeier ML, Scarlett LM, Knapp LT, Camper SA, Mahon KA. The Ames dwarf gene, df, is required early in pituitary ontogeny for the extinction of Rpx transcription and initiation of lineage-specific cell proliferation. Mol Endocrinol 1996; 10: 1570-1581.
2. Gage PJ, Roller ML, Saunders TL, Scarlett LM, Camper SA. Anterior pituitary cells defective in the cell-autonomous factor, df, undergo cell lineage specification but not expansion. Development 1996; 122: 151-160.
3. Cogan JD, Wu W, Phillips JA, Arnhold IJ, Agapito A, Fofanova OV, Osorio MG, Bircan I, Moreno A, Mendonca BB. The PROP1 2-base pair deletion is a common cause of combined pituitary hormone deficiency. J Clin Endocrinol Metab 1998; 83: 3346-3349. (Pubitemid 28500983)
4. Fofanova O, Takamura N, Kinoshita E, Parks JS, Brown MR, Peterkova VA, Evgrafov OV, Goncharov NP, Bulatov AA, Dedov II, Yamashita S. Compound heterozygous deletion of the PROP-1 gene in children with combined pituitary hormone deficiency. J Clin Endocrinol Metab 1998; 83: 2601-2604. (Pubitemid 28503072)
5. Parks JS, Brown MR. Transcription factors regulating pituitary development. Growth Horm IGF Res 1999; 9 (Suppl B):2-8; discussion 8-11.
6. Parks JS, Tenore A, Bongiovanni AM, Kirkland RT. Familial hypopituitarism with large sella turcica. N Engl J Med 1978; 298: 698-702. (Pubitemid 8312846)
7. Riepe FG, Partsch CJ, Blankenstetn O, Mönig H, Pfäffle RW, Sippell WG. Longitudinal imaging reveals pituitary enlargement preceding hypoplasia in two brothers with combined pituitary hormone deficiency attributable to PROP1 mutation. J Clin Endocrinol Metab 2001; 86: 4353-4357.
8. Mody S, Brown MR, Parks JS. The spectrum of hypopituitarism caused by PROP1 mutations. Best Pract Res Clin Endocrinol Metab 2002; 16: 421-431. (Pubitemid 35345195)
9. Dattani MT, Robertson IC. The molecular basis for developmental disorders of the pituitary gland in man. Clin Genet 2000; 57: 337-346.
10. Nascif SO, Vieira TC, Ramos-Dias JC, Lengyel AM, Abucham J. Waxing and waning of a pituitary mass in a young woman with combined pituitary hormone deficiency (CPHD) due to a PROP-1 mutation. Pituitary 2006; 9: 47-52. (Pubitemid 43733082)
11. Xekouki P, Sertedaki A, Livadas S, Argyropoulou M, Voutetakis A. PROP1 gene mutations and pituitary size: a unique case of two consecutive cycles of enlargement and regression. Horm Res 2007; 67 (Suppl 1): 109-113. (Pubitemid 46272289)
12. Voutetakis A, Sertedaki A, Livadas S, Xekouki P, Bossis I, Dacou-Voutetakis C, Argyropoulou MI. Pituitary size fluctuation in long-term MR studies of PROP1 deficient patients: a persistent pathophysiological mechanism? J Endocrinol Invest 2006; 29: 462-466.
13. Voutetakis A, Argyropoulou M, Sertedaki A, Livadas S, Xekouki P, Maniati-Christidi M, Bossis I, Thalassinos N, Patronas N, Dacou-Voutetakis C. Pituitary magnetic resonance imaging in 15 patients with PROP1 gene mutations: pituitary enlargement may originate from the intermediate lobe. J Clin Endocrinol Metab 2004; 89: 2200-2206. (Pubitemid 38619853)
14. Ward RD, Raetzman LT, Suh H, Stone BM, Nasonkin IO, Camper SA. Role of PROP1 in pituitary gland growth. Mol Endocrinol 2005; 19: 698-710. (Pubitemid 40349441)
15. th Annual Meeting of the Endocrine Society, 1998; 470.
16. rd Ed. Philadelphia, PA: Lippincott Williams &Wilkins, 2007; 321-344.
17. Giangaspero F, Cenacchi G. Oncocytic and granular cell neoplasms of the central nervous system and pituitary gland. Semin Diagn Pathol 1999; 16: 91-97. (Pubitemid 29357966)
18. Niveiro M, Aranda FI, Paya A, Boix E, Peiró G, Picó A. Oncocytic transformation in pituitary adenomas: immunohistochemical analyses of 65 cases. Arch Pathol Lab Med 2004; 128: 776-780. (Pubitemid 38856888)
19. Vankelecom H. Stem cells in the postnatal pituitary? Neuroendocrinology 2007; 85: 110-130
20. Zygmunt-Gorska A, Starzyk J, Sucharski P, Herman-Sucharska I, Adamek D, Pietrzyk JJ. Radiological and histological assessment of pituitary in patients with combined pituitary hormone deficiency due to PROP-1 gene mutation. Horm Res 2007; 68 (Suppl 1): 39.